Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Mol Psychiatry ; 19(8): 937-46, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24061497

ABSTRACT

The loss of synapses is a strong histological correlate of the cognitive decline in Alzheimer's disease (AD). Amyloid ß-peptide (Aß), a cleavage product of the amyloid precursor protein (APP), exerts detrimental effects on synapses, a process thought to be causally related to the cognitive deficits in AD. Here, we used in vivo two-photon microscopy to characterize the dynamics of axonal boutons and dendritic spines in APP/Presenilin 1 (APP(swe)/PS1(L166P))-green fluorescent protein (GFP) transgenic mice. Time-lapse imaging over 4 weeks revealed a pronounced, concerted instability of pre- and postsynaptic structures within the vicinity of amyloid plaques. Treatment with a novel sulfonamide-type γ-secretase inhibitor (GSI) attenuated the formation and growth of new plaques and, most importantly, led to a normalization of the enhanced dynamics of synaptic structures close to plaques. GSI treatment did neither affect spines and boutons distant from plaques in amyloid precursor protein/presenilin 1-GFP (APPPS1-GFP) nor those in GFP-control mice, suggesting no obvious neuropathological side effects of the drug.


Subject(s)
Amyloid Precursor Protein Secretases/antagonists & inhibitors , Dendritic Spines/pathology , Plaque, Amyloid/drug therapy , Presynaptic Terminals/pathology , Quinolines/pharmacology , Sulfonamides/pharmacology , Amyloid beta-Protein Precursor/genetics , Animals , Enzyme Inhibitors/pharmacology , Male , Mice , Mice, Transgenic , Microscopy, Fluorescence, Multiphoton , Plaque, Amyloid/pathology , Presenilin-1/genetics , Quinolines/therapeutic use , Sulfonamides/therapeutic use
2.
Biol Reprod ; 64(6): 1784-9, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11369609

ABSTRACT

Translational regulation of the protamine 1 mRNA is mediated by sequences in its 3' untranslated region. In this study, we demonstrate that a highly conserved sequence, the translational control element, is solely responsible for protamine 1 translational regulation. Mutation of the conserved sequence causes premature translation of a transgene containing a fusion between the human growth hormone coding sequence and the protamine 1 3' untranslated region. Temporal expression of the transgene was monitored in prepubertal animals by Northern and Western blotting and in adult animals by immunocytochemistry. Messenger RNAs lacking the translational control element sediment in the messenger ribonucleoprotein particle and ribosomal fractions of polysome gradients, suggesting that the translational control element is required for translational repression but not for incorporation of mRNAs into ribonucleoprotein particles.


Subject(s)
Conserved Sequence , Gene Expression Regulation , Protamines/genetics , Protein Biosynthesis , RNA, Messenger/analysis , Spermatids/metabolism , Acrosome/metabolism , Animals , Base Sequence , Blotting, Northern , Blotting, Western , Human Growth Hormone/genetics , Humans , Immunohistochemistry , Male , Mice , Mice, Transgenic , Molecular Sequence Data , Mutation , Recombinant Fusion Proteins
3.
Proc Natl Acad Sci U S A ; 96(4): 1716-21, 1999 Feb 16.
Article in English | MEDLINE | ID: mdl-9990090

ABSTRACT

The mammalian protein ZnT3 resides on synaptic vesicle membranes of zinc-containing neurons, suggesting its possible role in vesicular zinc transport. We show here that histochemically reactive zinc, corresponding to the zinc found within synaptic vesicles, was undetectable in the brains of mice with targeted disruption of the ZnT3 gene. Total zinc levels in the hippocampus and cortex of these mice were reduced by about 20%. The ultrastructure of mossy fiber boutons, which normally store the highest levels of vesicular zinc, was unaffected. Mice with one normal ZnT3 allele had reduced levels of ZnT3 protein on synaptic vesicle membranes and had intermediate amounts of vesicular zinc. These results demonstrate that ZnT3 is required for transport of zinc into synaptic vesicles and suggest that vesicular zinc concentration is determined by the abundance of ZnT3.


Subject(s)
Brain/metabolism , Carrier Proteins/metabolism , Membrane Proteins/metabolism , Synaptic Vesicles/metabolism , Zinc/metabolism , Animals , Carrier Proteins/genetics , Cation Transport Proteins , Cerebellum/metabolism , Cerebral Cortex/metabolism , Gene Expression Regulation , Hippocampus/metabolism , Immunohistochemistry , Membrane Proteins/genetics , Membrane Transport Proteins , Mice , Mice, Knockout , Promoter Regions, Genetic , Synaptic Vesicles/ultrastructure
4.
Oncogene ; 18(4): 877-86, 1999 Jan 28.
Article in English | MEDLINE | ID: mdl-10023663

ABSTRACT

Multiple endocrine neoplasia type 2B (MEN2B) is an autosomal dominant syndrome characterized by the development of medullary thyroid carcinoma, pheochromocytomas, musculoskeletal anomalies and mucosal ganglioneuromas. MEN2B is caused by a specific mutation (Met918-->Thr) in the RET receptor tyrosine kinase. Different mutations of RET lead to other conditions including MEN2A, familial medullary thyroid carcinoma and intestinal aganglionosis (Hirschsprung disease). Transgenic mice were created using the dopamine beta-hydroxylase promoter to direct expression of RET(MEN2B) in the developing sympathetic and enteric nervous systems and the adrenal medulla. DbetaH-RET(MEN2B) transgenic mice developed benign neuroglial tumors, histologically identical to human ganglioneuromas, in their sympathetic nervous systems and adrenal glands. The enteric nervous system was not affected. The neoplasms in DbetaH-RET(MEN2B) mice were similar to benign neuroglial tumors induced in transgenic mice by activated Ras expression under control of the same promoter. Levels of phosphorylated MAP kinase were not increased in the RET(MEN2B)-induced neurolglial proliferations, suggesting that alternative pathways may play a role in the pathogenesis of these lesions. Transgenic mice with the highest levels of DbetaH-RET(MEN2B) expression, unexpectedly developed renal malformations analogous to those reported with loss of function mutations in the Ret gene.


Subject(s)
Adrenal Gland Neoplasms/genetics , Drosophila Proteins , Ganglioneuroma/genetics , Gene Expression Regulation , Kidney/abnormalities , Multiple Endocrine Neoplasia Type 2a/genetics , Proto-Oncogene Proteins/genetics , Receptor Protein-Tyrosine Kinases/genetics , Sympathetic Nervous System , Adrenal Glands/innervation , Adrenal Glands/pathology , Animals , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Humans , Hyperplasia/genetics , Mice , Mice, Transgenic , Peripheral Nervous System Neoplasms/genetics , Proto-Oncogene Proteins c-ret , Sympathetic Nervous System/pathology
5.
Nat Med ; 4(6): 718-21, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9623983

ABSTRACT

Neuropeptide Y (NPY), a 36-amino-acid neuromodulator abundantly expressed in the brain, has been implicated in the regulation of food intake and body weight. Pharmacological data suggest that NPY's stimulatory effect on appetite is transduced by the G-protein-coupled NPY Y5 receptor (Y5R). We have inactivated the Y5R gene in mice and report that younger Y5R-null mice feed and grow normally; however, they develop mild late-onset obesity characterized by increased body weight, food intake and adiposity. Fasting-induced refeeding is unchanged in younger Y5R-null mice and they exhibit normal sensitivity to leptin. Their response to intracerebroventricular (i.c.v.) administration of NPY and related peptides is either reduced or absent. NPY deficiency attenuates the obesity syndrome of mice deficient for leptin (ob/ob), but these effects are not mediated by NPY signaling through the Y5R because Y5R-null ob/ob mice are equally obese. These results demonstrate that the Y5R contributes to feeding induced by centrally administered NPY and its analogs, but is not a critical physiological feeding receptor in mice.


Subject(s)
Feeding Behavior/physiology , Obesity/physiopathology , Receptors, Neuropeptide Y/genetics , Receptors, Neuropeptide Y/physiology , Animals , Body Weight/genetics , Body Weight/physiology , Dose-Response Relationship, Drug , Feeding Behavior/drug effects , Female , Genotype , Humans , Leptin , Male , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Mice, Mutant Strains , Molecular Sequence Data , Mutagenesis, Site-Directed , Mutation/genetics , Neuropeptide Y/administration & dosage , Neuropeptide Y/genetics , Neuropeptide Y/pharmacology , Obesity/genetics , Pancreatic Polypeptide/administration & dosage , Pancreatic Polypeptide/pharmacology , Peptide YY/administration & dosage , Peptide YY/pharmacology , Peptides, Cyclic/administration & dosage , Peptides, Cyclic/pharmacology , Phenotype , Proteins/administration & dosage , Proteins/pharmacology , RNA, Messenger/analysis , RNA, Messenger/genetics , Receptors, Neuropeptide Y/antagonists & inhibitors , Time Factors
6.
J Int Neuropsychol Soc ; 3(2): 108-19, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9126852

ABSTRACT

Clinically, tests of executive functions tend to be chosen on face validity. If such tests are to be used to evaluate a clinical population, their ability to measure executive functions should be reliably demonstrated in a normal population. In order to investigate the reliability of such tests, a sample of 130 normal adults (74 women, 56 men) ages 17 to 55 years were administered 4 tests purporting to measure planning/problem-solving: the Tower of London Test, the Six Element Test, the Twenty Questions Test, and the Rey Complex Figure Test. A structural equation modeling approach provided by the LISREL 8 program was used to evaluate three models hypothesized to explain the relationship among the test variables and the latent construct of planning/problem-solving. An adequate model was unable to be estimated, thus raising questions about the meaning of the latent construct planning/problem-solving and the psychometric structure of the Tower of London Test.


Subject(s)
Neuropsychological Tests/statistics & numerical data , Problem Solving , Adolescent , Adult , Female , Humans , Male , Mathematical Computing , Middle Aged , Psychometrics , Reference Values , Reproducibility of Results
7.
Oncogene ; 15(23): 2783-94, 1997 Dec 04.
Article in English | MEDLINE | ID: mdl-9419969

ABSTRACT

Sympathetic neurons, enteric neurons and adrenal chromaffin cells all derive from the neural crest. During development these cells migrate, proliferate, survive and differentiate in a highly controlled fashion influenced by local signals encountered during their migration. Aberrations of these processes are responsible for a variety of developmental defects and malignancies. Many of the environmental signals influencing these precursor cells activate receptor tyrosine kinases that can signal, at least in part, via Ras pathways. To assess the extent to which Ras can alter neuroblast cell number and fate in vivo, we expressed activated H-Ras in transgenic mice using the dopamine-beta-hydroxylase promoter, which directs expression to these cells prior to and after their differentiation. Ganglioneuromas and occasional neuroblastomas formed in the adrenal gland and preaortic sympathetic ganglia. Curiously, neurons of the superior cervical ganglia and the gut were largely unaffected despite demonstrated expression of activated Ras. The sensitivity of preaortic sympathetic neurons and adrenal chromaffin cells to the effects of oncogenes such as Ras may explain the predilection of neuroblastomas in humans to these sites. The ability to analyse neuroblastoma development in these mice may shed light on the molecular basis of certain types of human neuroblastoma.


Subject(s)
Cell Transformation, Neoplastic/pathology , Neurons/pathology , ras Proteins/metabolism , Adrenal Glands/pathology , Adrenal Medulla/innervation , Adrenal Medulla/pathology , Aneuploidy , Animals , Cell Differentiation , Cell Transformation, Neoplastic/metabolism , Chromosome Aberrations/genetics , Chromosome Disorders , Dopamine beta-Hydroxylase/genetics , Female , Ganglia, Sympathetic/pathology , Genes, myc , Humans , Hyperplasia , Karyotyping , Male , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Mice, Transgenic , Neurites/pathology , Neuroblastoma/genetics , Neurons/metabolism , RNA, Messenger/metabolism , Signal Transduction/genetics , ras Proteins/genetics
8.
Unfallchirurgie ; 16(4): 196-201, 1990 Aug.
Article in German | MEDLINE | ID: mdl-2219545

ABSTRACT

The management of patients with antero-medial rotatory instability of the knee is described. The therapy of the special patient depends on the age of the patient and the extent of instability. The therapy is also influenced by the degree of degenerative arthritis and differs between well trained and untrained persons.


Subject(s)
Joint Instability/therapy , Knee Injuries/complications , Knee Joint , Adult , Age Factors , Aged , Algorithms , Arthroscopy , Combined Modality Therapy , Humans , Joint Instability/diagnosis , Middle Aged , Physical Fitness
SELECTION OF CITATIONS
SEARCH DETAIL
...